Altium Capital Management’s DexCom DXCM Stock Holding History

Altium Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-44,000	Closed	-$3.28M	–	141
2022 Q2	$3.28M	Sell	44,000 -6,000	-12%	-$548K	1.31%	26
2022 Q1	$6.39M	Buy	+50,000	New	+$5.47M	2.14%	8
2021 Q1	–	Sell	-22,000	Closed	-$2.03M	–	131
2020 Q4	$2.03M	Buy	+22,000	New	+$1.96M	0.76%	59

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Altium Capital Management's DXCM Position: Q3 2022 in Review

Altium Capital Management sold out of DexCom (DXCM) in Q3 2022, closing a stake of 44,000 shares — an estimated $3.28M sold.

Altium Capital Management first reported a position in DXCM in Q4 2020 and held it in 3 quarters. The position peaked at $6.39M in Q1 2022. 795 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

Altium Capital Management reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
Altium Capital Management sold 44,000 DexCom shares in Q3 2022, an estimated $3.28M.
Altium Capital Management first reported a position in DexCom in Q4 2020 and held it in 3 quarters.
Altium Capital Management's DexCom position peaked at $6.39M in Q1 2022.
795 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on Altium Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.